1,1-dichloroethene increases expression ISO RGD:1550440 6480464 vinylidene chloride results in increased expression of ESPL1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:1550440 6480464 1, 2-Dimethylhydrazine results in increased expression of ESPL1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ESPL1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol multiple interactions ISO RGD:1550440 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ESPL1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1550440 6480464 Ethinyl Estradiol results in increased expression of ESPL1 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1550440 6480464 Estradiol results in increased expression of ESPL1 mRNA CTD PMID:25210133 17beta-estradiol increases expression ISO RGD:1314788 6480464 Estradiol results in increased expression of ESPL1 mRNA CTD PMID:18310284 , PMID:19167446 17beta-estradiol multiple interactions ISO RGD:1550440 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of ESPL1 mRNA] CTD PMID:25210133 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1550440 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1550440 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550440 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ESPL1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ESPL1 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1550440 6480464 Tetrachlorodibenzodioxin results in increased expression of ESPL1 mRNA CTD PMID:21496263 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314788 6480464 Tetrachlorodibenzodioxin results in increased expression of ESPL1 mRNA CTD PMID:21496263 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314788 6480464 Tetrachlorodibenzodioxin affects the expression of ESPL1 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550440 6480464 Tetrachlorodibenzodioxin affects the expression of ESPL1 mRNA CTD PMID:21570461 2,4-diaminotoluene increases expression ISO RGD:1550440 6480464 2, 4-diaminotoluene results in increased expression of ESPL1 mRNA CTD PMID:20713471 3-methylcholanthrene increases expression ISO RGD:1550440 6480464 Methylcholanthrene results in increased expression of ESPL1 mRNA CTD PMID:20713471 4-hydroxynon-2-enal decreases expression ISO RGD:1550440 6480464 4-hydroxy-2-nonenal results in decreased expression of ESPL1 mRNA CTD PMID:19191707 5-fluorouracil affects response to substance ISO RGD:1314788 6480464 ESPL1 protein affects the susceptibility to Fluorouracil CTD PMID:15548681 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ESPL1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of ESPL1 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ESPL1 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1314788 6480464 Acrylamide results in decreased expression of ESPL1 mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ESPL1 mRNA CTD PMID:23630614 , PMID:25378103 antirheumatic drug decreases expression ISO RGD:1314788 6480464 Antirheumatic Agents results in decreased expression of ESPL1 mRNA CTD PMID:24449571 arsenite(3-) multiple interactions ISO RGD:1314788 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ESPL1 mRNA] CTD PMID:32406909 atrazine increases expression ISO RGD:1314788 6480464 Atrazine results in increased expression of ESPL1 mRNA CTD PMID:22378314 azathioprine decreases expression ISO RGD:1314788 6480464 Azathioprine results in decreased expression of ESPL1 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ESPL1 mRNA CTD PMID:21839799 benzo[a]pyrene increases methylation ISO RGD:1314788 6480464 Benzo(a)pyrene results in increased methylation of ESPL1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1550440 6480464 Benzo(a)pyrene results in increased expression of ESPL1 mRNA CTD PMID:32417428 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1314788 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ESPL1 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1314788 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ESPL1 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1550440 6480464 bisphenol A results in decreased expression of ESPL1 mRNA CTD PMID:29161229 bisphenol A decreases methylation ISO RGD:1550440 6480464 bisphenol A results in decreased methylation of ESPL1 promoter CTD PMID:27312807 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ESPL1 gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:1314788 6480464 bisphenol A results in increased expression of ESPL1 mRNA CTD PMID:27685785 bleomycin A2 multiple interactions ISO RGD:1550440 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of ESPL1 mRNA], lenabasum inhibits the reaction [Bleomycin results in decreased expression of ESPL1 mRNA] CTD PMID:30825431 bleomycin A2 decreases expression ISO RGD:1550440 6480464 Bleomycin results in decreased expression of ESPL1 mRNA CTD PMID:30825431 butanal decreases expression ISO RGD:1314788 6480464 butyraldehyde results in decreased expression of ESPL1 mRNA CTD PMID:26079696 caffeine decreases phosphorylation ISO RGD:1314788 6480464 Caffeine results in decreased phosphorylation of ESPL1 protein CTD PMID:35688186 calcitriol decreases expression ISO RGD:1314788 6480464 Calcitriol results in decreased expression of ESPL1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1314788 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ESPL1 mRNA CTD PMID:21592394 cannabidiol multiple interactions ISO RGD:1550440 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of ESPL1 mRNA] CTD PMID:30825431 carbon nanotube increases expression ISO RGD:1550440 6480464 Nanotubes more ... CTD PMID:25554681 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of ESPL1 mRNA CTD PMID:18500788 choline multiple interactions ISO RGD:1550440 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ESPL1 mRNA CTD PMID:20938992 cobalt dichloride decreases expression ISO RGD:1314788 6480464 cobaltous chloride results in decreased expression of ESPL1 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1314788 6480464 [Chelating Agents binds to Copper] which results in decreased expression of ESPL1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1314788 6480464 [Chelating Agents binds to Copper] which results in decreased expression of ESPL1 mRNA CTD PMID:30911355 copper(II) sulfate decreases expression ISO RGD:1314788 6480464 Copper Sulfate results in decreased expression of ESPL1 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1314788 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1314788 6480464 Coumestrol results in increased expression of ESPL1 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1314788 6480464 Asbestos, Crocidolite results in increased expression of ESPL1 mRNA CTD PMID:25351596 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ESPL1 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:1314788 6480464 Cyclosporine results in decreased expression of ESPL1 mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of ESPL1 mRNA] CTD PMID:20032058 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of ESPL1 mRNA CTD PMID:20032058 diazinon affects expression EXP 6480464 Diazinon affects the expression of ESPL1 mRNA CTD PMID:22546817 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ESPL1 mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:1314788 6480464 dicrotophos results in increased expression of ESPL1 mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of ESPL1 mRNA CTD PMID:22546817 dioxygen decreases expression ISO RGD:1314788 6480464 Oxygen deficiency results in decreased expression of ESPL1 mRNA CTD PMID:26516004 Echimidine multiple interactions ISO RGD:1314788 6480464 [CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of ESPL1 mRNA CTD PMID:33884520 Enterolactone multiple interactions ISO RGD:1314788 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ESPL1 mRNA CTD PMID:19167446 folic acid multiple interactions ISO RGD:1550440 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ESPL1 mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:1314788 6480464 Folic Acid results in decreased expression of ESPL1 mRNA CTD PMID:21867686 fulvestrant decreases expression ISO RGD:1314788 6480464 fulvestrant results in decreased expression of ESPL1 mRNA CTD PMID:19016759 fulvestrant multiple interactions ISO RGD:1314788 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ESPL1 gene, [Fulvestrant co-treated with Sirolimus] results in decreased expression of ESPL1 mRNA CTD PMID:19016759 , PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of ESPL1 mRNA CTD PMID:25539665 genistein decreases expression ISO RGD:1550440 6480464 Genistein results in decreased expression of ESPL1 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ESPL1 mRNA CTD PMID:22061828 geraniol decreases expression ISO RGD:1314788 6480464 geraniol results in decreased expression of ESPL1 mRNA CTD PMID:27683099 glyphosate decreases expression ISO RGD:1314788 6480464 glyphosate results in decreased expression of ESPL1 mRNA CTD PMID:31295307 GW 4064 increases expression ISO RGD:1314788 6480464 GW 4064 results in increased expression of ESPL1 mRNA CTD PMID:31437187 L-methionine multiple interactions ISO RGD:1550440 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ESPL1 mRNA CTD PMID:20938992 Lasiocarpine multiple interactions ISO RGD:1314788 6480464 [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ESPL1 mRNA CTD PMID:33884520 lead(0) affects expression ISO RGD:1314788 6480464 Lead affects the expression of ESPL1 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1314788 6480464 Lead affects the expression of ESPL1 mRNA CTD PMID:28903495 leflunomide decreases expression ISO RGD:1314788 6480464 leflunomide results in decreased expression of ESPL1 mRNA CTD PMID:28988120 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of ESPL1 mRNA CTD PMID:35283115 lucanthone decreases expression ISO RGD:1314788 6480464 Lucanthone results in decreased expression of ESPL1 mRNA CTD PMID:21148553 monocrotaline multiple interactions ISO RGD:1314788 6480464 [CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of ESPL1 mRNA CTD PMID:33884520 N-Nitrosopyrrolidine decreases expression ISO RGD:1314788 6480464 N-Nitrosopyrrolidine results in decreased expression of ESPL1 mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1314788 6480464 Nickel results in increased expression of ESPL1 mRNA CTD PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of ESPL1 mRNA CTD PMID:22546817 O-methyleugenol decreases expression ISO RGD:1314788 6480464 methyleugenol results in decreased expression of ESPL1 mRNA CTD PMID:32234424 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of ESPL1 mRNA CTD PMID:19237604 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of ESPL1 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ESPL1 mRNA CTD PMID:25729387 paracetamol increases expression ISO RGD:1314788 6480464 Acetaminophen results in increased expression of ESPL1 mRNA CTD PMID:22230336 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ESPL1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1314788 6480464 Acetaminophen results in decreased expression of ESPL1 mRNA CTD PMID:29067470 PCB138 multiple interactions ISO RGD:1550440 6480464 [2 more ... CTD PMID:25510870 perfluorononanoic acid decreases expression ISO RGD:1314788 6480464 perfluoro-n-nonanoic acid results in decreased expression of ESPL1 mRNA CTD PMID:32588087 phenethyl isothiocyanate decreases expression ISO RGD:1314788 6480464 phenethyl isothiocyanate results in decreased expression of ESPL1 mRNA CTD PMID:26678675 phenobarbital affects expression ISO RGD:1550440 6480464 Phenobarbital affects the expression of ESPL1 mRNA CTD PMID:23091169 phytoestrogen increases expression ISO RGD:1314788 6480464 Phytoestrogens results in increased expression of ESPL1 mRNA CTD PMID:18310284 pirinixic acid multiple interactions ISO RGD:1314788 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ESPL1 mRNA CTD PMID:19710929 propanal decreases expression ISO RGD:1314788 6480464 propionaldehyde results in decreased expression of ESPL1 mRNA CTD PMID:26079696 resveratrol multiple interactions ISO RGD:1314788 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of ESPL1 mRNA, [Plant Extracts co-treated with Resveratrol] results in decreased expression of ESPL1 mRNA CTD PMID:19167446 , PMID:23557933 riddelliine multiple interactions ISO RGD:1314788 6480464 [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of ESPL1 mRNA CTD PMID:33884520 silicon dioxide increases expression ISO RGD:1550440 6480464 Silicon Dioxide results in increased expression of ESPL1 mRNA CTD PMID:29341224 sirolimus multiple interactions ISO RGD:1314788 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of ESPL1 mRNA CTD PMID:19016759 sodium arsenite increases expression ISO RGD:1550440 6480464 sodium arsenite results in increased expression of ESPL1 protein CTD PMID:16338954 sodium arsenite decreases expression ISO RGD:1314788 6480464 sodium arsenite results in decreased expression of ESPL1 protein CTD PMID:30528433 sodium arsenite affects expression ISO RGD:1314788 6480464 sodium arsenite affects the expression of ESPL1 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:1314788 6480464 sodium arsenite results in increased expression of ESPL1 mRNA CTD PMID:29301061 sunitinib decreases expression ISO RGD:1314788 6480464 Sunitinib results in decreased expression of ESPL1 mRNA CTD PMID:31533062 testosterone decreases expression ISO RGD:1314788 6480464 Testosterone results in decreased expression of ESPL1 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of ESPL1 mRNA] CTD PMID:20032058 testosterone multiple interactions ISO RGD:1314788 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ESPL1 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1550440 6480464 Carbon Tetrachloride results in increased expression of ESPL1 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ESPL1 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression ISO RGD:1550440 6480464 titanium dioxide results in increased expression of ESPL1 mRNA CTD PMID:23557971 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of ESPL1 mRNA CTD PMID:30012374 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of ESPL1 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ESPL1 mRNA CTD PMID:25729387 trimellitic anhydride increases expression ISO RGD:1550440 6480464 trimellitic anhydride results in increased expression of ESPL1 mRNA CTD PMID:19042947 Triptolide increases expression EXP 6480464 triptolide results in increased expression of ESPL1 mRNA CTD PMID:23639586 troglitazone decreases expression ISO RGD:1314788 6480464 troglitazone results in decreased expression of ESPL1 mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO RGD:1550440 6480464 trovafloxacin results in decreased expression of ESPL1 mRNA CTD PMID:35537566 tunicamycin decreases expression ISO RGD:1314788 6480464 Tunicamycin results in decreased expression of ESPL1 mRNA CTD PMID:22378314 valproic acid increases methylation ISO RGD:1314788 6480464 Valproic Acid results in increased methylation of ESPL1 gene CTD PMID:29154799